Does Dupilumab Improve Sinonasal Outcomes in AERD Patients?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40116354.
- Also identified by DOI 10.1002/lary.32099.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This Best Practice review synthesizes evidence from five key clinical trials to evaluate whether dupilumab improves sinonasal outcomes in AERD patients who have undergone prior endoscopic sinus surgery.
Medical subject headings
- Antibodies, Monoclonal, Humanized
- Sinusitis
- Rhinitis